Aytu BioPharma Inc.

NASDAQ: AYTU · Real-Time Price · USD
2.21
0.02 (0.91%)
At close: Aug 15, 2025, 3:59 PM
2.24
1.36%
After-hours: Aug 15, 2025, 05:41 PM EDT

Aytu BioPharma Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
1.64M -5.24M -6.25M -15.84M -13.68M -18M -22.29M -17.05M -32.3M -78.17M -85.2M -110.17M -111.47M -83.86M -81.83M -58.29M -42.44M -22.31M -13M
Depreciation & Amortization
6.66M 7.14M 7.98M 8.78M 8.32M 8.72M 8.72M 8.81M 8.95M 9.4M 9.9M 10.25M 6.9M 10.54M 9.79M 9.2M 12.77M 8.1M 7.47M
Stock-Based Compensation
815K 1.49M 2.04M 2.8M 3.35M 3.44M 5.8M 6.05M 6.38M 6.74M 4.91M 5.25M 5.11M 5.36M 4.64M 3.57M 2.97M 1.71M 1.37M
Other Working Capital
-10.35M -8.61M -13.88M -9.37M 216K 7.87M 7.64M 2.58M -10.38M -14.24M -20.12M -11.01M -2.05M -5.05M 3.4M 596K 226.21K 2.91M -313.78K
Other Non-Cash Items
-14.6M 2.29M 2.63M 12.15M 10.88M 2.81M 2M -3.81M 9.85M 56.48M 57.28M 56.96M 36.84M -7.35M -4.12M -4.46M -2.26M -1.87M -10.39M
Deferred Income Tax
n/a n/a 659K 639K 7.31M 7.31M 6.65M 6.67M -19.75M -19.75M -19.66M n/a 34.15M 41.57M 41.88M 22.33M 8.51M 1.09M 687.88K
Change in Working Capital
-42K 374K -4.16M -4.66M -2.16M 1.71M 2.93M -5.8M -14.47M -22.26M -21.16M -10.86M 450.15K 6.06M 7.88M 1.68M -6.99M -16.91M -19.5M
Operating Cash Flow
-5.53M 673K -2.37M -1.39M 8.77M 6.11M 3.81M -5.13M -21.59M -27.8M -34.18M -28.82M -28.01M -27.68M -21.78M -25.96M -27.44M -30.19M -33.36M
Capital Expenditures
-211K -142K -136K n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.34M -2.34M -2.34M -2.34M n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a -5K n/a -5K -5K -40K -74K -3.13M -3.18M -5.6M -5.89M -2.85M -2.82M -411.21K 250.1K 211.19K
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
634K 589K 264K -329K -445K -404K -235K -117K 32K -5K 8K -70K -25.08K -624.56K -638.68K -600.48K -638.4K 1.35M -3.49M
Investing Cash Flow
423K 447K 128K -329K -450K -404K -235K -117K -3K -74K -3.12M -3.25M -5.62M -5.87M -2.85M -2.78M -409.13K 252.18K -4.63M
Debt Repayment
-14.96M -14.43M -13.92M -15.36M -8.72M -6.34M -6.76M -2.5M 6.92M 4.02M 6.87M -814K 1.33M -4.93M -7.29M -3.99M -6.53M 367K 504K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
15.79M 10.8M 12.84M 10.63M -1.67M -3.42M -5.81M -4.21M -5.77M -10.36M -8.13M -9.35M 432.96K 6.65M 1.76M 2.05M -20.32M 47.36M 61.66M
Financial Cash Flow
3.52M -251K 2.38M -1.26M -7.73M -5.68M -7.42M 8.87M 13.16M 12.1M 20.55M 1.53M 14.46M 6.54M 27.03M 30.31M 12.13M 86.71M 68.89M
Net Cash Flow
-1.59M 869K 144K -2.98M 581K 28K -3.85M 3.63M -8.43M -15.78M -16.75M -30.54M -19.18M -27.01M 2.4M 1.57M -15.73M 56.77M 30.9M
Free Cash Flow
-5.74M 531K -2.5M -1.39M 8.77M 6.11M 3.81M -5.13M -21.59M -27.8M -34.18M -28.82M -30.36M -30.02M -24.12M -28.3M -27.44M -30.19M -33.36M